References
- Sharland M, Rodvold KA, Tucker HR, et al. Safety and efficacy of tigecycline to treat multidrug-resistant infections in pediatrics: an evidence synthesis. Pediatr Infect Dis J. 2019 Jul;38:710–715.
- Kaewpoowat Q, Ostrosky-Zeichner L. Tigecycline: a critical safety review. Expert Opin Drug Saf. 2015;14:335–342.
- Kadoyama K, Sakaeda T, Tamon A, et al. Adverse event profile of tigecycline: data mining of the public version of the U.S. Food and Drug Administration adverse event reporting system. Biol Pharm Bull. 2012;35:967–970.
- Sami G, Zaher SA, Reem IB, et al. Severe coagulation disorder and thrombocytopenia associated with tigecycline – case report and review of literature. Curr Drug Saf. 2017;12:7–9.
- Kaufmann D, Pichler W, Beer JH. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne. Arch Intern Med. 1994;154:1983–1984.
- Parneix-Spake A, Bastuji-Garin S, Lobut JB, et al. Minocycline as possible cause of severe and protracted hypersensitivity drug reaction. Arch Dermatol. 1995;131:490–491.
- MacNeil M, Haase DA, Tremaine R, et al. Fever, lymphadenop eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline. J Am Acad Dermatol. 1997;36:347–350.
- Naranjo CA, Shear NH, Lanctot KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol. 1992;32:897–904.
- Hung WY, Kogelman L, Volpe G. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents. 2009;34:486–489.
- Chatham WW, Ross DW. Leukemoid blood reaction to tetracycline. South Med J. 1983;76:1195–1196.